Samsung Bioepis

Did you know that women face higher risk for chronic diseases, research gaps, and—in the US—higher out-of-pocket costs, which could lead to less effective treatment? ? Expanding women’s access to care will help bridge disparities and create a healthier future for all. At Samsung Bioepis, we are committed to making this a reality. ? #IWD2025 #AccelerateAction #InnovatingAccess

??? The FDA’s first biosimilar approval was a game-changer, making treatments more accessible in the US. ? ?? Keep up with our “Today in Biosimilars” series to explore more key milestones in biosimilar history, from approvals to breakthroughs. #TodayInBiosimilars #PassionForHealth #InnovatingAccess #biosimilars

How often do you give your eyes a break? This Save Your Vision month, remember to focus on healthy eye care habits. Blink. Look away. Breathe. ?? #SamsungBioepis #SaveYourVision #vision #eyecare

Samsung Bioepis is committed to?rare?disease treatment in support of patients with devastating conditions. Started in 2008, Rare Disease Day is observed every year on February 28 (or 29 in leap years) – the rarest day of the year. Fill your home with color at 7 pm and share your story online with the hashtag?#LightUpForRare?to support 300 million people worldwide living with a rare disease. #RareDiseaseDay #PassionForHealth

Since 2012, Samsung Bioepis has been driven by a bold vision for accessible healthcare. On our 13th anniversary, our CEO Kyung-ah Kim shares what's next. Hear from 13 voices across our team on their hopes for 2025: https://bit.ly/3Xk5kSp #13YearsOfSamsungBioepis #Anniversary #PassionForHealth

13 years of expanding access. 13 years of changing lives. Our people are at the heart of everything we do. With our 13th anniversary approaching, Samsung Bioepis employees are sharing their vision for the road ahead. Special thanks to the employees featured in?our?three-part anniversary video series. Marcel Janis Beha, Ph.D., Kevin Jack, Paola Russo, Inbeom Song,?Jaeyeol "Jay" Hyun #13YearsOfSamsungBioepis #PassionForHealth #InnovatingAccess

13 years strong, and we are just getting started. As we count down to our anniversary, we heard from a handful of our employees who have made this journey possible. Meet 13 Samsung Bioepis employees sharing why 2025 is a milestone year for innovation, collaboration, and expanding access to healthcare. A heartfelt thank you to everyone who shared their thoughts in our three-part video series. Anouk Ammerlaan, Antonio Rito, Thomas M. Newcomer, MBA, Angi Martin, Jinhyuk Kim #13YearsOfSamsungBioepis?#PassionForHealth #InnovatingAccess

Regulatory news: We are expanding our biosimilars portfolio. Our latest regulatory milestones have enabled a new therapeutic option in endocrinology. We’re proud to continue our commitment to innovation and patient care.? https://bit.ly/4hY8MtL #Biosimilars #InnovatingAccess #PassionforHealth?

Science advances when all voices are empowered. At Samsung Bioepis, we take an active approach to innovation, harnessing diversity to fuel progress. Meet the women visionaries of our team Jieun Shin and ??? as they share their journeys, challenges, and insights into the future of biosimilars: https://lnkd.in/gz56366M #WomenInScience #InclusionMatters #Biosimilars

Behind every cancer experience is a unique story of resilience, hope, and care. That’s why cancer care must be people-centered, ensuring treatments meet individual needs.? ? ???Together, we can build a future that puts people first. #PassionForHealth #InnovatingAccess #WorldCancerDay #UnitedByUnique